EPSTEIN-BARR VIRUS INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: THE ROLE OF CYTOMEGALOVIRUS
EHA Library, Qifa Liu, 54424
AUTOLOGOUS BONE MARROW MONONUCLEAR CELLS AND PLATELET-RICH PLASMA ENHANCED RECONSTRUCTION OF THE MAXILLOFACIAL BONY DEFECTS
EHA Library, Alaa Eldin Abdelhamid, 54423
ALPHA/BETA T- CELL DEPLETED ALLOGENEIC STEM CELL TRANSPLANTATION FROM MATCHED RELATED AND UNRELATED DONOR GRAFTS
EHA Library, Moniek de Witte, 54422
THE PERIPHERAL BLOOD STEM CELL COLLECTION BY EDAP FOLLOWING INITIAL THERAPY WITH COMBINING BORTEZOMIB AND DEXAMETHASONE IS EFFECTIVE IN YOUNG MULTIPLE MYELOMA PATIENTS
EHA Library, Naoki Takezako, 54421
ASSOCIATION OF EPSTEIN-BARR VIRUS WITH REGRESSION AFTER WITHDRAWAL OF METHOTREXATE AND PROGRESSION OF IATROGENIC IMMUNODEFICIENCY-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS IN AUTOIMMUNE DISEASE
EHA Library, Katsuya Fujimoto, 54420
SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR (IL2-R), INTERLEUKIN-6 (IL-6) AND TUMOUR NECROSIS FACTOR (TNF) CORRELATE WITH ADVERSE CLINICAL FEATURES AND POOR OUTCOME IN DIFFUSE LARGE B CELL LYMPHOMA
EHA Library, Ivan Dlouhy, 54418
HUMAN MONOCYTE-DERIVED DENDRITIC CELLS EXPOSED TO HYPERTHERMIA SHOW A DISTINCT GENE EXPRESSION PROFILE AND SELECTIVE UPREGULATION OF IGFBP-6
EHA Library, Arcangelo Liso, 53578
INCIDENCE OF EBV-POSITIVITY IN THE VERY ELDERLY PATIENTS (AGED ? 80 YEARS) WITH DIFFUSE LARGE B-CELL LYMPHOMA: POSSIBLE NEW SUBTYPE OF ELDERLY DLBCL
EHA Library, Tatsuki Tomikawa, 54417
LOW-DOSE BORTEZOMIB SENSITIZES MULTIPLE MEYLOMA TO GAMMA-DELTA T CELLS LYSIS
EHA Library, Jiuwei Cui, 53577
IDENTIFYING MALIGNANT LYMPH NODES BY NANOPARTICLE MODELLING AND SIMULATIONS: A PRELIMINARY INVESTIGATION
EHA Library, Giacoma De Tullio, 54416
IMMUNOPHENOTYPIC PROFILE AND FUNCTIONAL CHARACTERISTICS OF NK CELLS EXPANDED FROM CYTOMEGALOVIRUS SEROPOSITIVE AND SERONEGATIVE DONORS: IMPLICATIONS FOR NEW STRATEGIES OF ADOPTIVE CELLULAR THERAPIES
EHA Library, Nadia Peragine, 53575
HYPOMETHYLATING AGENT AZACITIDINE INDUCES FOXP3 NEGATIVE HLA-G EXPRESSING IMMUNOREGULATORY T CELLS.
EHA Library, MARIA LIGA, 53574
AN EFFICIENT AND COST EFFECTIVE METHOD FOR THE GENERATION OF CLINICALLY RELEVANT NUMBERS OF MYELOID CORD BLOOD-DERIVED DENDRITIC CELLS BY EMPLOYING CLINICALLY APPROVED AGENTS
EHA Library, Panayotis Kaloyannidis, 53573
CLINICAL OUTCOME AND PROGNOSIS IN PATIENTS WITH PRIMARY SINONASAL TRACT DIFFUSE LARGE B CELL LYMPHOMA TREATED WITH R-CHOP CHEMOTHERAPY: MULTICENTER RETROSPECTIVE ANALYSIS
EHA Library, Gyeong-Won Lee, 54413
DESIGNING TCR SPECIFIC FOR HUMAN MDM2 TUMOR-ASSOCIATED ANTIGEN FOR ADOPTIVE IMMUNOTHERAPY AGAINST MELANOMA AND MULTIPLE MYELOMA
EHA Library, Eva Amann, 53572
THE ROLE OF IMAGE GUIDED CORE BIOPSY IN THE DIAGNOSIS OF HAEMATOLOGICAL MALIGNANCY
EHA Library, Katharine Bailey, 54412
CYTOMEGALOVIRUS-SPECIFIC CYTOTOXIC T LYMPHOCYTES RESTRICTED TO HLA-A2 OR HLA-A24 CAN BE EFFICIENTLY GENERATED BY USING GENE-ENGINEERED ARTIFICIAL ANTIGEN-PRESENTING CELLS
EHA Library, Masahiro Ogasawara, 53571
EVALUATION OF THE NOVEL, ORALLY BIOAVAILABLE SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) VERDINEXOR (KPT-335) IN SPONTANEOUS CANINE CANCERS: RESULTS OF PHASE I AND PHASE II CLINICAL TRIALS
EHA Library, CHRISTINE CHEN, 54411
ADOPTIVE CIK CELLS IN PATIENTS WITH LEUKEMIA RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Qing Li, 53570
TORISEL IN MANTLE CELL LYMPHOMA: RESULTS OF RESTOR STUDY (NON INTERVENTIONAL, LONGITUDINAL, RETROSPECTIVE, MULTICENTER AND NATIONAL STUDY ON A COHORT OF 93 PATIENTS WITH MANTLE CELL LYMPHOMA)
EHA Library, Kamal Bouabdallah, 54410
HDAC6 INHIBITION AUGMENTS THE EFFICACY OF ANTI-CD20 MONOCLONAL ANTIBODIES BY UP-REGULATING CD20 LEVEL IN MALIGNANT B-CELLS
EHA Library, Malgorzata Bobrowicz, 53569
MONOCLONAL AND POLYCLONAL GAMMOPATHY MEASURED BY SERUM FREE LIGHT CHAIN AND IMMUNOFIXATION SUBDIVIDE THE CLINICAL OUTCOMES OF DIFFUSE LARGE B-CELL LYMPHOMA ACCORDING TO MOLECULAR CLASSIFICATION
EHA Library, Yu Ri Kim, 54409
COMBINING ADOPTIVE TCR IMMUNOTHERAPY AND ARGININE DEPLETION IN OSTEOSARCOMA XENOGRAFT MODEL
EHA Library, Hakim Echchannaoui, 53568
CNS PROPHYLAXIS IN PATIENTS WITH DLBCL, ARE WE TREATING OURSELVES? A RESPONSE TO THE RECENT BCSH GUIDELINE.
EHA Library, Morag Griffin, 54408
OPTIMIZING TUMOR-REACTIVE SINGLE-CHAIN T CELL RECEPTORS FOR ADOPTIVE T CELL TRANSFER
EHA Library, Beate Hauptrock, 53567
ABNORMAL IMMUNOPHENOTYPE IS OF GREAT VALUE IN THE DIAGNOSIS OF AGGRESSIVE NATURAL KILLER CELL LEUKEMIA
EHA Library, Zhi-Yuan Qiu, 54407
FUNCTIONAL EVALUATION OF T-CELLS GENERATED FROM WT1-TCR TRANSDUCED HUMAN HEMATOPOIETIC STEM CELLS USING THE OP9-DL1 COCULTURE SYSTEM.
EHA Library, Tessa Kerre, 53566
RETROSPECTIVE ANALYSIS OF TREATMENT OUTCOMES FOR 120 CASES OF NATURAL KILLER/T CELL LYMPHOMA, NASAL TYPE AT THE LARGEST SINGLE HOSPITAL OF NORTH-WESTERN CHINA
EHA Library, Rong Liang, 54406
NEXT-GENERATION DENDRITIC CELL VACCINATION AS POSTREMISSION THERAPY FOR AML PATIENTS WITH A NON-FAVORABLE RISK PROFILE
EHA Library, Felix Lichtenegger, 53565
DEFINING ACCURACY AND SENSITIVITY OF T-CELL RECEPTOR REPERTOIRE PROFILING FOR MONITORING RECURRENT/PERSISTENT DISEASE IN PATIENTS WITH MATURE T-CELL NEOPLASMS
EHA Library, Catherine Sanders, 54405
GENETIC CORRECTION OF DIFFERENTLY MOBILIZED HEMATOPOIETIC STEM CELLS FROM PATIENTS WITH THALASSEMIA AND ENGRAFTMENT KINETICS AFTER XENOTRANSPLANTATION
EHA Library, Garyfalia Karponi, 53564
COMBINING SEVERAL MOLECULAR ABNORMALITIES IN IDENTIFICATION OF HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA IMPROVES RISK-STRATIFICATION
EHA Library, Idun Fiskvik, 54404
VITAMIN D DEFICIENCY (VDD) IMPAIRS RITUXIMAB-MEDIATED CELLULAR CYTOTOXICITY AND OUTCOME OF DLBCL PATIENTS TREATED WITH, BUT NOT WITHOUT RITUXIMAB (R)
EHA Library, Viola Pöschel, 54403
ADOPTIVE TRANSFER OF RAPIDLY GENERATED EBV-CTLS FOR THE TREATMENT OF HIGH RISK ASSOCIATED EBV MALIGNANCIES
EHA Library, Serena Perna, 53562
BONE MARROW INVOLVEMENT AT DIAGNOSIS IS A POOR PROGNOSTIC FACTOR IN YOUNG PATIENTS WITH UNTREATED HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA: SUB-ANALYSIS OF THE PHASE III RANDOMIZED FIL-DLCL04 TRIAL
EHA Library, Annalisa Chiappella, 54402
THE αβ-DNTS IN LYMPH NODES, BONE MARROW AND PERIPHERAL BLOOD OF LYMPHOMA PATIENTS: POTENTIAL PROGNOSTIC FACTOR OF CLINICAL OUTCOME.
EHA Library, Giacoma De Tullio, 53560
IN VITRO AND IN VIVO EFFECT OF ATO/IFN/AZT FOR ADULT T CELL LEUKEMIA/LYMPHOMA
EHA Library, Makoto Yoshimitsu, 54399
MIR-150 REGULATES IL-22-CCL20-CCR6 AUTOCRINE PATHWAY IN METASTATIC CUTANEOUS T- CELL LYMPHOMA
EHA Library, Kazuaki Teshima, 54398
COMPREHENSIVE CYTOGENETIC AND MOLECULAR GENETIC CHARACTERIZATION OF T-PLL
EHA Library, Anna Stengel, 54397
IMPACT OF CONSOLIDATION WITH BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE (VTD) UPFRONT IN MULTIPLE MYELOMA (MM) WITH PARTIAL RESPONSE (PR) AT COMPLETION OF INDUCTION WITH VTD
EHA Library, Xavier Leleu, 53556
ROLE AND RELATIONSHIP OF INTERLEUKIN-6 AND -15 IN T LARGE GRANULAR LYMPHOCYTE LEUKEMIA
EHA Library, Antonella Teramo, 54395
MICRORNA (MIRNA) EXPRESSION PROFILING IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) TREATED WITH CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (CRD)
EHA Library, Andrzej J. Jakubowiak, 53555
SUBMICROSCOPIC GENOMIC REARRANGEMENTS CHANGE GENE EXPRESSION IN T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA
EHA Library, Katarzyna Izykowska, 54394
OVERALL SURVIVAL OF PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: ADJUSTING FOR CROSSOVER IN THE MM-003 TRIAL FOR POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE
EHA Library, Gareth Morgan, 53554
BACH2 SUPPRESSION IN CD4+ T CELLS MODULATES THEIR RESISTANCE TO APOPTOSIS DEMONSTRATING ITS FUNCTION AS A TUMOR SUPPRESSOR GENE
EHA Library, Vu Luan Dang Chi, 54393
CYTOGENETICS AND LONG-TERM SURVIVAL IN MM-003, A PHASE 3 TRIAL OF POMALIDOMIDE + LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
EHA Library, Meletios Dimopoulos, 53553
THE RIZ1 GENE EXPRESSION IS SUPPRESSED IN T CELL LYMPHOMA AND THAT EXPRESSION IS CORRELATED WITH THE DECREASED GATA3 GENE EXPRESSION
EHA Library, Hanae Shimura, 54392
PHASE 3 STUDY OF POMALIDOMIDE + LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: MM-003 SUBANALYSIS OF ELDERLY PATIENTS (> 65 AND > 70 YEARS OF AGE)
EHA Library, Katja Weisel, 53552
GENOME-WIDE DNA METHYLATION ANALYSIS REVEALS ACTIVATION OF WNT SIGNALING PATHWAY IN PERIPHERAL T-CELL LYMPHOMA-NOT OTHERWISE SPECIFIED
EHA Library, Xia Zhao, 54391
Exposure-safety-efficacy analysis of investigational oral ixazomib in relapsed/refractory multiple myeloma (MM): Phase 3 dose selection for maintenance post-autologous stem cell transplant
EHA Library, Neeraj Gupta, 53551
ISOLD: A VALUABLE SCORE TO DISCRIMINATE OCULAR LYMPHOMA FROM INFLAMMATORY DISEASES
EHA Library, Myrto Costopoulos, 54390
PANOBINOSTAT IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE (VPD) AS INDUCTION THERAPY IN PATIENTS WITH MULTIPLE MYELOMA CANDIDATES TO AUTOLOGOUS TRANSPLANT
EHA Library, SILVIA MANGIACAVALLI, 53550
WHOLE-BODY LOW-DOSE CT (WBLDCT) IS USEFUL FOR DETECTION, STAGING, RESPONSE EVALUATION AND FOLLOW-UP IN MYELOMA PATIENTS
EHA Library, Sara Pezzatti, 53549
COMPARISON OF CONVENTIONAL CYTOGENETIC ANALYSIS AND WHOLE GENOME SEQUENCING IN GERMINAL-CENTER DERIVED B-CELL LYMPHOMAS IN THE FRAMEWORK OF THE ICGC MMML-SEQ PROJECT
EHA Library, Cristina Lopez, 54388
BENDAMUSTINE AND PREDNISONE IN COMBINATION WITH BORTEZOMIB (BPV) IN THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED/UNTREATED MULTIPLE MYELOMA.
EHA Library, Wolfram Poenisch, 53548
Effects of single-agent bortezomib as post-transplant consolidation on multiple myeloma-related bone disease: First results from a multicenter, randomized phase 2 study
EHA Library, Orhan Sezer, 53547
HIGH-THROUGHPUT ANALYSIS OF FULL-LENGTH IMMUNOGLOBULIN TRANSCRIPTS BY TEMPLATE-SWITCHING ANCHORED PCR AND MASSIVE PARALLEL SEQUENCING ON THE PACBIO PLATFORM
EHA Library, Marvyn Koning, 54387
Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: Subanalysis of patients with renal impairment in the phase 3 MMY-3021 study
EHA Library, Philippe Moreau, 53545
FIRST-LINE THERAPY FOR MULTIPLE MYELOMA (MM): RESULTS FROM THE SECOND INTERIM ANALYSIS OF THE REAL-WORLD, INTERNATIONAL, NON-INTERVENTIONAL EMMOS STUDY
EHA Library, Mohamad Mohty, 53544
A PROFILE OF 140 LONG-TERM SURVIVORS WITH SYSTEMIC AL AMYLOIDOSIS
EHA Library, Sajitha Sachchithanantham, 53543
INTRACELLULAR SIGNALING PATHWAYS IN HAIRY CELL LEUKEMIA (HCL) AND THEIR PROGNOSTIC RELEVANCE
EHA Library, Maria K Angelopoulou, 54383
IMPAIRED RHOA FUNCTION LEADS TO DEVELOPMENT OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
EHA Library, Terukazu Enami, 54381
ANTI-TUMOR ACTIVITY OF SELINEXOR (KPT-330), AN ORAL SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE), ± DEXAMETHASONE IN MULTIPLE MYELOMA PRECLINICAL MODELS & TRANSLATION IN PATIENTS WITH MULTIPLE MYELOMA
EHA Library, CHRISTINE CHEN, 53540
TREATMENT OF ELDERLY PATIENTS WITH HODGKIN LYMPHOMA: EXPERIENCE OF A SINGLE UNIT
EHA Library, Francesca Pierdomenico, 54380
VALIDATION OF BI-SPECIFIC T-CELL ENGAGER (BITE®) ANTIBODY ACTIVITY IN VITRO AND IN VIVO AGAINST DIFFERENTIALLY EXPRESSED CELL SURFACE TARGETS IN ACUTE MYELOID LEUKEMIA
EHA Library, Angus Sinclair, 54143
PRE-CLINICAL ACTIVITY OF THE PI3K INHIBITOR BKM120 ON ACUTE MYELOID LEUKEMIA
EHA Library, Matteo Allegretti, 54138
CABOZANTINIB IS SELECTIVELY CYTOTOXIC IN ACUTE MYELOID LEUKEMIA CELLS WITH INTERNAL TANDEM DUPLICATION OF FLT3 (FLT3-ITD)
EHA Library, Liang-In Lin, 54137
THE COMBINATION OF SELINEXOR (KPT-330), A SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE), & THE FLT3 INHIBITOR QUIZATINIB SHOWS ANTI-TUMOR ACTIVITY IN ACUTE MYELOID LEUKEMIA (AML) IN-VITRO AND IN-VIVO
EHA Library, CHRISTINE CHEN, 54136
EXPRESSION OF FLT3-ITD DYSREGULATES THE DBC1-SIRT1-P53 SIGNALING AND PROMOTES THERAPY RESISTANCE
EHA Library, Daniel Sasca, 54135
NFATC1 MEDIATES SORAFENIB RESISTANCE IN FLT3-ITD POSITIVE ACUTE MYELOID LEUKEMIA
EHA Library, Andreas Burchert, 54134
FREQUENT MUTATIONS IN PML-RARA IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA
EHA Library, Annette Fasan, 54133
PSEUDO-EXHAUSTION OF T CELLS IN RELAPSED AML
EHA Library, Felix Lichtenegger, 54131
THE PROGNOSTIC VALUE OF LEUKEMIC STEM CELLS IN PEDIATRIC AML.
EHA Library, Bram De Caluwé, 54129
CD123 (IL-3R?) IS CONSISTENTLY EXPRESSED ON ACUTE MYELOID LEUKEMIA (AML) CARRYING NUCLEOPHOSMIN (NPM1) GENE MUTATION
EHA Library, Lorenzo Brunetti, 54128
ANALYSIS OF NPM1 SPLICE VARIANTS REVEALS DIFFERENTIAL EXPRESSION PATTERNS OF PROGNOSTIC VALUE IN ACUTE MYELOID LEUKEMIA
EHA Library, Malgorzata Zajac, 54126
DEVELOPMENT OF MOLECULAR BEACON BASED PCR ASSAY FOR EASY DETECTION AND QUANTIFICATION OF CHIMERIC TRANSCRIPTS OF AML-ETO [T(8;21)] IN ACUTE MYELOID LEUKEMIA PATIENTS
EHA Library, Rashi Arora, 54125
GSX2 DEREGULATION IN CD7+ ACUTE MYELOID LEUKEMIA BEARING 4Q12 TRANSLOCATIONS WITHOUT FUSION GENES
EHA Library, Danika Di Giacomo, 54122
THE CXCR4 ANTAGONIST BL-8040 SYNERGIZES WITH THE FLT3 INHIBITOR AC220 TO INDUCE APOPTOSIS AND REDUCE MINIMAL RESIDUAL DISEASE OF AML CELLS IN VIVO
EHA Library, Michal Abraham, 54139
DECREASE EXPRESSION OF MIR-20A PROMOTES CANCER CELL PROLIFERATION AND PREDICTS POOR SURVIVAL OF ACUTE MYELOID LEUKEMIA
EHA Library, Zhang Nan, 54119
ENDOCRINE SIDE EFFECTS AFTER CHEMOTHERAPY IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Yesim Oymak, 54117
LENALIDOMIDE FOR TREATMENT OF REFRACTORY/RELAPSED ADULT B-ALL PATIENTS: RESULTS OF A MULTICENTRIC PHASE 2 STUDY.
EHA Library, Tavernier-Tardy Emmanuelle, 54116
MOLECULAR CYTOGENETIC ANALYSIS IN 108 CHILDHOOD ACUTE LEUKEMIA PATIENTS FROM SAUDI ARABIA: CORRELATION TO MOLECULAR AND OTHER BIOLOGIC FACTORS
EHA Library, Yasser Elborai, 54115
ASPARAGINASE-ASSOCIATED PANCREATITIS (AAP) DURING TREATMENT FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
EHA Library, Teresa Garrido, 54114
INVASIVE FUNGAL INFECTIONS IN PEDIATRIC PATIENTS WITH ACUTE LEUKEMIA: RESULTS FROM AN UNIVERSITY HOSPITAL, 2005 TO 2013
EHA Library, Zumrut Sahbudak Bal, 54113
RELATIONSHIP BETWEEN MTHFR POLYMORPHISM AND SIDE EFFECTS OF HIGH-DOSE METHOTREXATE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Seham Ragab, 54110
QUANTITATIVE ULTRASOUND OF PROXIMAL PHALANXES IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA SURVIVORS
EHA Library, Antonia De Matteo, 54109
TREATMENT OF RELAPSED ACUTE LEUKEMIA AFTER ALLO-HSCT BY SALVAGE CHEMOTHERAPY WITH LOW-DOSE CYTARABINE AND ACLARUBICIN COMBINED WITH G-CSF PRIMING: MORE EFFECTIVE AND LESS TOXIC?
EHA Library, Depei Wu, 54108
FREQUENCY AND CLINICAL SIGNIFICANCE OF OCCULT CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS
EHA Library, Jordi Vila-Bou, 54107
6-MERCAPTOPURINE DOSAGE REDUCTION AND TPMT POLYMORPHISMS IN THE TREATMENT OF CHILDREN ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Ana Ferreira Baptista, 54106
AUTOPHAGY INDUCED BY DEXAMETHASONE MEDIATES GLUCOCORTICOID RESISTANCE IN LYMPHOID MALIGNANCY CELLS
EHA Library, Lei Jiang, 54102
A COMPREHENSIVE NEW DNA TEST FOR DETECTION OF FUSION GENES IN LEUKEMIA
EHA Library, Eva Van Den Berg-De Ruiter, 54101
IMMUNE STATUS IN RELATION TO THE TREATMENT OF CHILDHOOD BCP-ALL ACCORDING TO THE NOPHO ALL2008 PROTOCOL
EHA Library, Bibi Fatima Syed Shah, 54100
SIGNIFICANCE OF ADDITIONAL STRUCTURAL ABERRATIONS IN BONE MARROW CELLS OF 115 CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND HIGH HYPERDIPLOIDY
EHA Library, Libuse Lizcova, 54099
CD20 EXPRESSION IN ADULTS WITH PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) FROM UKALL14, ITS REGULATION BY DEXAMETHASONE AND RITUXIMAB INDUCED CYTOTOXICITY
EHA Library, Brendan Beaton, 54094
THE DIFFERENCE OF RCSD1-ABL1-LEUKEMOGENICITY BETWEEN EXON3 OF RCSD1/EXON 4 OF ABL1 AND EXON 2 OF RCSD1/EXON 4 OF ABL1
EHA Library, Hayato Tamai, 54093
COMPLEX GENETIC HETEROGENEITY INFLUENCES PROGNOSIS IN ADULT B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA NEGATIVE FOR RECURRENT FUSION GENES
EHA Library, Ilaria Iacobucci, 54088
TARGETING THE DOPAMINE RECEPTOR SIGNALING REDUCES THE POLYCOMB PROTEIN BMI1 AND LIMITS THE SELF-RENEWAL OF BCR-ABL1 POSITIVE LEUKEMIA CELLS
EHA Library, Tetsuzo Tauchi, 54087
CHARACTERIZATION OF THE RARE TRANSLOCATION T(3;10)(Q26;Q21) IN AN ACUTE MYELOID LEUKEMIA PATIENT
EHA Library, Tereza Jancuskova, 54121

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings